Antenatal factors related to congenital toxoplasmosis in Rio De Janeiro, Brazil

References

• Tizard IR, Chauhan SS, Lai CH. The prevalence and epidemiology of toxoplasmosis in Ontario. J Hyg. 1977;78(2):275–282.
   PubMedGoogle Scholar
• Taylor MRH, Lennon B, Holland CV, et al. Community study of toxoplasma antibodies in urban and rural schoolchildren aged 4 to 18 years. Arch Dis Child. 1997;77(5):406–409.
   PubMed Web of Science ®Google Scholar
• Price C, Wilkins PP, Kruszon-Moran D, et al. Toxoplasma gondii seroprevalence in the United States 2009-2010 and comparison with the past two decades. Am J Trop Med Hyg. 2014;90(6):1135–1139.
   PubMed Web of Science ®Google Scholar
• Contopoulos-Ioannidis D, Montoya JG. Toxoplasmosa gondii and toxoplasmosis. In: Long S, Pickering L, Prober C, editors. Principals and practice of pediatric infectious diseases. Philadelphia: Sanders; 2013.
   Google Scholar
• Wolf A, Cowen D, Paige B. Human toxoplasmosis: occurrence in infants as an encephalomyelitis. Verification by transmission to animals. Science. 1939;89(2306):226–227.
   PubMedGoogle Scholar
• Remington JS. Toxoplasmosis. In: Remington JS, editor. Infectious disease of the fetus and newborn infant. Philadelphia: Saunders; 2010. p. 947–1091.
   Google Scholar
• Koppe JG, Kloosterman GJ, de Roever-Bonnet H, et al. Toxoplasmosis and pregnancy, with a long-term follow-up of the children. EUR J Obstet Gynec Reprod Biol. 1974;4(3):101–110.
   Web of Science ®Google Scholar
• Boyer KM, Holfels E, Roizen N, et al. Risk factors for Toxoplasma gondii infection in mothers of infants with congenital toxoplasmosis: Implications for prenatal management and screening. A J Obstet Gynecol. 2005;192(2):564–571.
   PubMed Web of Science ®Google Scholar
• Boyer K, Hill D, Mui E, et al. Unrecognized ingestion of Toxoplasma gondii oocysts leads to congenital toxoplasmosis and causes epidemics in North America. Clin Infect Dis. 2011;53(11):1081–1089.
   PubMed Web of Science ®Google Scholar
• Torgerson PR, Mastroiacovo P. The global burden of congenital toxoplasmosis: a systematic review. Bull World Health Organ. 2013;91(7):501–508.
   PubMed Web of Science ®Google Scholar
• Neto EC, Anele E, Rubim R, et al. High prevalence of congenital toxoplasmosis in Brazil estimated in a 3-year prospective neonatal screening study. Int J Epidemiol. 2000;29(5):941–947.
   PubMed Web of Science ®Google Scholar
• Maldonado YA, Read JS. Diagnosis, treatment, and prevention of congenital toxoplasmosis in the United States. Pediatrics. 2017;139(2):e20163860.
   PubMed Web of Science ®Google Scholar
• Desmonts G, Couvreur J. Congenital toxoplasmosis. A prospective study of 378 pregnancies. N Engl J Med. 1974;290(20):1110–1116.
   PubMed Web of Science ®Google Scholar
• Desmonts G, Couvreur J. Toxoplasmosis in pregnancy and its transmission to the fetus. Bull N Y Acad Med. 1974; 50(2):146–159.
   PubMedGoogle Scholar
• Forestier F. Fetal diseases, prenatal diagnosis and practical measures. Press Med. 1991;20(30):1448–1454.
   PubMed Web of Science ®Google Scholar
• Petersen E, Vesco G, Villari S, et al. What do we know about risk factors for infection in humans with Toxoplasma gondii and how can we prevent infections? Zoonoses Public Health. 2010;57(1):8–17.
   PubMed Web of Science ®Google Scholar
• Bahia-Oliveira LMG, Jones JL, Azevedo-Silva J, et al. Highly endemic, waterborne toxoplasmosis in north Rio de Janeiro state. Emerg Infect Dis. 2003;9(1):55–62.
   PubMed Web of Science ®Google Scholar
• Gilbert RE, Freeman K, Lago EG, et al. Ocular sequelae of congenital toxoplasmosis in Brazil compared with Europe. PLoS Negl Trop Dis. 2008;2(8):e277.
   PubMed Web of Science ®Google Scholar
• Melamed J, Eckert GU, Spadoni VS, et al. Ocular manifestations of congenital toxoplasmosis. Eye. 2010;24(4):528–534.
   PubMed Web of Science ®Google Scholar
• Kimberlin DW, Brady MT, Jackson MA, et al. RedBook 2015 report of the committee of infectious diseases. Elk Grove Village (IL): American Academy of Pediatrics; 2015. p. 787.
   Google Scholar
• Kieffer F, Wallon M. Congenital toxoplasmosis. In: Dulac O, Lassonde M, Sarnet HB, editors. Handbook of clinical neurology. Amsterdam: Elsevier; 2013. p. 1099–1101.
   Google Scholar
• Peyron F, Lobry JR, Musset K, et al. Serotyping of Toxoplasma gondii in chronically infected pregnant women: predominance of type II in Europe and types I and III in Colombia (South America). Microbes Infect. 2006;8(9–10):2333–2340.
   PubMed Web of Science ®Google Scholar
• SYRICOT. Effectiveness of prenatal treatment for congenital toxoplasmosis: a meta-analysis of individual patients' data. Lancet. 2007;369(9556):115–122.
   PubMed Web of Science ®Google Scholar
• Lago EG, Oliveira AP, Bender AL. Presence and duration of anti-Toxoplasma gondii imunoglobulin M in infants with congenital toxoplasmosis. J Pediatri. 2014;90(4):363–369.
   Google Scholar
• Vasconcelos-Santos DV, Machado Azevedo DO, Campos WR, et al. Congenital toxoplasmosis in southeastern Brazil: results of early ophthalmologic examination of a large cohort of neonates. Ophthalmology. 2009;116(11):2199–2205 e1.
   PubMed Web of Science ®Google Scholar
• Olariu TR, Remington JS, McLeod R, et al. Severe congenital toxoplasmosis in the United States: clinical and serologic findings in untreated infants. Pediatr Infect Dis J. 2011;30(12):1065–1061.
   Web of Science ®Google Scholar
• Wallon M, Peyron F, Cornu C, et al. Congenital toxoplasma infection: monthly prenatal screening decreases transmission rate and improves clinical outcome at age 3 years. Clin Infect Dis. 2013;53(9):1223–1231.
   Google Scholar
• Wallon M, Dunn D, Slimani D, et al. Diagnosis of congenital toxoplasmosis at birth: what is the value of testing for IgM and IgA? Eur J Pediatr. 1999;158(8):645–649.
   PubMed Web of Science ®Google Scholar
• Olariu TR, Press C, Talucod J, et al. Congenital toxoplasmosis in the United States: clinical and serologic findings in infants born to mothers treated during pregnancy. Parasite. 2019;26:13.
   PubMedGoogle Scholar
• Alford CA, Stagno S, Reynolds DW. Congenital toxoplasmosis: clinical, laboratory, and therapeutic considerations, with special reference to subclinical disease. Bull N Y Acad Med. 1974;50(2):160–181.
   PubMedGoogle Scholar
• Dubey JP, Lago EG, Gennari SM, et al. Toxoplasmosis in humans and animals in Brazil: high prevalence, high burden of disease, and epidemiology. Parasitology. 2012;139(11):1375–1424.
   PubMed Web of Science ®Google Scholar
• Jones JL, Dargelas V, Roberts J, et al. Risk factors for Toxoplasma gondii infection in the United States. Clin Infect Dis. 2009;49(6):878–884.
   PubMed Web of Science ®Google Scholar
• Gavinet MF, Robert F, Firtion G, et al. Congenital toxoplasmosis due to maternal reinfection during pregnancy. J Clin Microbiol. 1997;35(5):1276–1277.
   PubMed Web of Science ®Google Scholar
• Wallace MR, Rossetti RJ, Olson PE. Cats and toxoplasmosis risk in HIV-infected adults. JAMA. 1993;269(1):76–77.
   PubMed Web of Science ®Google Scholar
• Wainwright KE, Miller MA, Barr BC, et al. Chemical inactivation of Toxoplasma gondii oocysts in water. J Parasitol. 2007;93(4):925–931.
   PubMed Web of Science ®Google Scholar